Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Bastion

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic LeukemiaA Osterborg, M J Dyer, D Bunjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patientsC Thieblemont, Y Bastion, F Berger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Hepatic angiosarcoma in a patient with essential thrombocythaemia and Budd-Chiari syndromeC Marichy, C Dumontet, Y Bastion, et al.
Cancer Genetics and Cytogenetics|October 6, 1997
Unbalanced X;autosome translocation (X;18)(q13;p11) in a case of aggressive natural killer non-Hodgkin lymphomaE Callet-Bauchu, R Rimokh, S Gazzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patientsY Bastion, C Sebban, F Berger, et al.
Bulletin Du Cancer|January 1, 1992
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol]C Dumontet, Y Bastion, P Felman, et al.
Cancer|September 15, 1996
Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patientsP Brice, Y Bastion, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patientsK Warzocha, G Salles, J Bienvenu, et al.
Journal of Internal Medicine|August 1, 1996
POEMS syndrome, arterial thrombosis and thrombocythaemiaT Zenone, Y Bastion, G Salles, et al.
British Journal of Haematology|May 1, 1996
Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patientsG Salles, J Bienvenu, Y Bastion, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic LeukemiaA Osterborg, M J Dyer, D Bunjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patientsC Thieblemont, Y Bastion, F Berger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Hepatic angiosarcoma in a patient with essential thrombocythaemia and Budd-Chiari syndromeC Marichy, C Dumontet, Y Bastion, et al.
Cancer Genetics and Cytogenetics|October 6, 1997
Unbalanced X;autosome translocation (X;18)(q13;p11) in a case of aggressive natural killer non-Hodgkin lymphomaE Callet-Bauchu, R Rimokh, S Gazzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patientsY Bastion, C Sebban, F Berger, et al.
Bulletin Du Cancer|January 1, 1992
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol]C Dumontet, Y Bastion, P Felman, et al.
Cancer|September 15, 1996
Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patientsP Brice, Y Bastion, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patientsK Warzocha, G Salles, J Bienvenu, et al.
Journal of Internal Medicine|August 1, 1996
POEMS syndrome, arterial thrombosis and thrombocythaemiaT Zenone, Y Bastion, G Salles, et al.
British Journal of Haematology|May 1, 1996
Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patientsG Salles, J Bienvenu, Y Bastion, et al.
Pageof 6